
Desonide: A low-potency prescription steroid made for delicate skin. It is the usual step up from hydrocortisone for the face, the folds and young children. Eucrisa: A non-steroid ointment for mild to moderate eczema. It can be used on the face and in skin folds, and there is no limit on how long it can be used.


Choose as the step up from hydrocortisone for delicate skin — face, eyelids, folds and babies.
Choose for mild to moderate eczema when you want a non-steroid you can use anywhere, for as long as needed.
Can you take them together?
A common pairing: desonide for short flares, Eucrisa for steroid-free maintenance between them.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.










Activates steroid receptors: Binds receptors inside skin and immune cells. Turns down inflammatory signals: Changes gene activity to reduce inflammatory messengers. Eases redness and itch: Swelling and irritation settle as inflammation falls.
Simplified glucocorticoid receptor-mediated effects in steroid-responsive skin inflammation. Full effects also involve other pathways. No claim of antimicrobial action or cure; formulation and potency affect clinical use.

Blocks PDE4: Inhibits an enzyme that breaks down cAMP. Raises cAMP inside cells: Preserves a signal involved in regulating inflammation. Helps inflamed skin settle: Eczema redness and itch can improve.
PDE4 inhibition and increased intracellular cAMP are established. The exact link to clinical improvement is not fully defined; this is a simplified overview, not every downstream pathway.
When to Apply: Twice a day on the affected skin only, in a thin film. One fingertip unit, the amount along the last joint of an adult index finger, covers about two adult palms. Moisturizer goes on separately and continues after the course ends.
How to Start: Twice daily from day one until the rash is flat, not just calmer, usually one to two weeks. Two weeks is the usual limit on a face, up to four weeks on the body before review. In children, follow the prescriber's duration, not the size of the tube.
If It Irritates: Stinging is usually the base, not the drug, and likelier on broken skin or with an alcohol-containing gel or foam. The ointment settles it. Redness or itch that worsens over a week or two can be allergy to the steroid or a preservative, and needs a different product.
If It Is Not Working: Two weeks of proper twice-daily use is a fair test. If nothing changed, question the diagnosis, look for infection, and ask whether the site can take a stronger steroid. On thin skin the better next step is often a non-steroid such as tacrolimus.
When to Apply: A thin layer twice a day on the inflamed areas, on clean dry skin. Moisturizer goes everywhere, including over the top once it has settled.
How to Start: Twice daily from day one, on the flaring areas only, not over the whole body as a preventive. If the stinging is hard to tolerate, moisturize first and use the ointment straight from the fridge. The stinging usually fades within the first week.
If It Irritates: Burning or stinging for a few minutes after applying is the commonest effect, and usually not an allergy. It settles as the skin heals. Redness spreading beyond where you applied it, or stinging that gets worse rather than better after two weeks, should be reviewed.
If It's Not Working: There is one strength, so there is nothing to increase. Four weeks of proper twice-daily use is a fair trial. After that: a different non-steroid, a short steroid course to break the flare, or a look at what else is driving the rash.
No blood tests for a standard course in a healthy person. Monitoring is looking at the skin: did the rash clear, has the skin become thin or shiny, have small vessels or stretch marks appeared in the folds.
Children are watched more closely, not because desonide is dangerous but because they absorb proportionally more for their size. Prescribers watch how much is used per month, and whether a repeat pattern has quietly become daily use.
Low potency does not mean indefinite. Where a condition keeps flaring, the plan is short courses on flares with emollients doing the daily work, or a switch to a non-steroid such as tacrolimus or pimecrolimus for the face and folds. Around the eyes, prolonged steroid use of any potency raises the risk of glaucoma and cataract.
No blood tests and no routine monitoring. Very little reaches the bloodstream, and what does is broken down quickly, so nothing accumulates.
Monitoring is a review at about four weeks to decide whether it is working. Long term, this is a drug people can stay on: no maximum duration, no limit on the area treated, no rest period. That is the practical difference between it and a topical steroid.
The one thing worth watching is whether it is quietly standing in for treatment that would actually control the disease. Eczema that keeps escaping it needs a different plan, not more months of the same ointment.
Approximate windows, not promises.
First few minutesApplying it: A thin layer on the affected skin. Low potency, which suits the face, the eyelids and small children.
First few minutesApplying it: A thin layer twice a day. Stinging or warmth for a few minutes is common, worst in week one.
Days 1 to 3Itch first: Itching and stinging settle before the rash looks different, which is often what lets a child sleep.
Days 3 to 10Clearing: Redness fades and rough or weeping skin settles. Most facial flares are largely better here.
Weeks 1 to 2Judge it here: On the face, stop and reassess here. Facial and eyelid eczema settle without the thinning risk a stronger steroid carries, and seborrheic dermatitis improves in the same window.
Weeks 2 to 4Folds and the body: Intertrigo and fold rashes respond, and the mildness suits a site that absorbs heavily; any yeast needs treating too. On the body, about four weeks before review.
After stoppingMarks stay behind: Brown or gray patches where the rash was are pigment change, not scarring, and fade over weeks to months.
Days 1 to 7Adjusting: Stinging is at its worst now. Itch eases before the rash looks different.
Week 2Settling: Redness and scaling fade. Most of the stinging has gone.
Week 4Judge it here: The point the trials measured. A meaningful share of people reach clear or almost clear skin; a meaningful share do not. No change by four weeks means more time will not help.
OngoingFace, eyelids and folds: Its strongest case. Use it on and off as needed: no cumulative limit, no rest period, none of the thinning that limits steroids on thin skin.
Sorted by what to do about them.
Generic desonide cream, ointment and lotion are cheap and well covered. The branded gel and foam, easier to use on faces and hairy areas, cost considerably more, and plans often ask for a generic first.
It costs more than over-the-counter hydrocortisone, which needs no visit, and less than non-steroids like tacrolimus or crisaborole. If cost is a barrier, start with the cream or ointment.
Cost is the obstacle here, not safety. It has been brand-name with no stocked generic for most of its life, and the cash price for a large tube is high. Generic availability changes, so ask the pharmacy.
Prior authorization is common. Plans usually want a topical steroid first, sometimes a calcineurin inhibitor too, which is cheaper as a generic. A savings card exists for people with commercial insurance, with terms that change often.
Tube size matters more than with most creams, because it goes on twice a day over an area. A small tube covering a child's whole body lasts days. Ask for the size that matches the area treated.
Yes, by a step or two, and both are low potency. Well below mid-potency steroids like triamcinolone.
That is largely what it is for. Keep courses to about two weeks and stop once the rash is flat. Repeated face use is a reason to ask about a non-steroid.
A common choice in children, and some formulations are approved from a few months of age. Follow the prescriber's duration, and remember a diaper acts as a dressing.
A short course at this potency is unlikely to. Thinning comes from stronger steroids, thin sites and long use. Untreated eczema has its own costs: months of scratching and more pigment change.
It can, less readily than stronger steroids. Pale patches show more on deeper skin tones and recover slowly. Untreated inflammation also leaves light and dark marks.
Several steps of potency. Triamcinolone on a face or in a fold for two weeks can cause thinning and stretch marks desonide would not. Matching steroid to site is why both exist.
Probably the drug itself acting on inflamed skin, not the base. It is the commonest complaint, worst in the first days, and fades within a week.
Thin skin is where it makes the most sense and it is used there, but not in the eye itself. Keep it off the lid margin.
No, it is milder. Its advantage is delicate skin and long stretches without the thinning that limits steroids.
There is no set limit. On during flares, off in between, for as long as it helps.
It is licensed from three months of age.
Licensed for atopic dermatitis. Doctors sometimes use it off-label for other inflammatory rashes, where the evidence is thinner.